Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants.

D'Angio CT, Heyne RJ, O'Shea TM, Schelonka RL, Shankaran S, Duara S, Goldberg RN, Stoll BJ, Van Meurs KP, Vohr BR, Das A, Li L, Burton RL, Hastings B, Phelps DL, Sanchez PJ, Carlo WA, Stevenson DK, Higgins RD; NICHD Neonatal Research Network.

Pediatr Infect Dis J. 2010 Jul;29(7):600-6. doi: 10.1097/INF.0b013e3181d264a6.

PMID:
20234331
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.

Shinefield HR, Black S, Ray P, Chang I, Lewis N, Fireman B, Hackell J, Paradiso PR, Siber G, Kohberger R, Madore DV, Malinowski FJ, Kimura A, Le C, Landaw I, Aguilar J, Hansen J.

Pediatr Infect Dis J. 1999 Sep;18(9):757-63.

PMID:
10493334
[PubMed - indexed for MEDLINE]
3.

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group.

O'Brien KL, Swift AJ, Winkelstein JA, Santosham M, Stover B, Luddy R, Gootenberg JE, Nold JT, Eskenazi A, Snader SJ, Lederman HM.

Pediatrics. 2000 Nov;106(5):965-72.

PMID:
11061761
[PubMed - indexed for MEDLINE]
4.

Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants.

Madhi SA, Izu A, Violari A, Cotton MF, Panchia R, Dobbels E, Sewraj P, van Niekerk N, Jean-Philippe P, Adrian PV; CIPRA-4 team.

Vaccine. 2013 Jan 21;31(5):777-83. doi: 10.1016/j.vaccine.2012.11.076. Epub 2012 Dec 8.

PMID:
23228814
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants.

Shinefield H, Black S, Ray P, Fireman B, Schwalbe J, Lewis E.

Pediatr Infect Dis J. 2002 Mar;21(3):182-6.

PMID:
12005078
[PubMed - indexed for MEDLINE]
6.

Pneumococcal conjugate vaccine given shortly after birth stimulates effective antibody concentrations and primes immunological memory for sustained infant protection.

Scott JA, Ojal J, Ashton L, Muhoro A, Burbidge P, Goldblatt D.

Clin Infect Dis. 2011 Oct;53(7):663-70. doi: 10.1093/cid/cir444. Epub 2011 Aug 23.

PMID:
21865175
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa.

Huebner RE, Mbelle N, Forrest B, Madore DV, Klugman KP.

Pediatr Infect Dis J. 2002 Nov;21(11):1004-7.

PMID:
12442020
[PubMed - indexed for MEDLINE]
8.

Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.

Losonsky GA, Wasserman SS, Stephens I, Mahoney F, Armstrong P, Gumpper K, Dulkerian S, West DJ, Gewolb IH.

Pediatrics. 1999 Feb;103(2):E14.

PMID:
9925860
[PubMed - indexed for MEDLINE]
9.

Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine.

Akinsola AK, Ota MO, Enwere GC, Okoko BJ, Zaman SM, Saaka M, Nsekpong ED, Odutola AA, Greenwood BM, Cutts FT, Adegbola RA.

PLoS One. 2012;7(2):e31050. doi: 10.1371/journal.pone.0031050. Epub 2012 Feb 20.

PMID:
22363544
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.

Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H; ARIVAC Consortium.

Vaccine. 2009 May 5;27(20):2680-8. doi: 10.1016/j.vaccine.2009.02.059. Epub 2009 Feb 24.

PMID:
19428879
[PubMed - indexed for MEDLINE]
11.

Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.

O'Brien KL, Moisi J, Moulton LH, Madore D, Eick A, Reid R, Weatherholtz R, Millar E, Hu D, Hackell J, Kohberger R, Siber G, Santosham M.

J Infect Dis. 2007 Jul 1;196(1):104-14. Epub 2007 May 24.

PMID:
17538890
[PubMed - indexed for MEDLINE]
Free Article
12.

Immunogenicity of heptavalent conjugate vaccine against Streptococcus pneumoniae in premature babies with low birth weight.

Szynczewska E, Chlebna-Sokół D.

Pediatr Neonatol. 2014 Apr;55(2):101-7. doi: 10.1016/j.pedneo.2013.06.005. Epub 2013 Oct 12.

PMID:
24129355
[PubMed - in process]
13.

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants.

Zangwill KM, Greenberg DP, Chiu CY, Mendelman P, Wong VK, Chang SJ, Partridge S, Ward JI.

Vaccine. 2003 May 16;21(17-18):1894-900.

PMID:
12706674
[PubMed - indexed for MEDLINE]
14.

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.

Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA; PCV13 Infant Study Group.

Pediatrics. 2010 May;125(5):866-75. doi: 10.1542/peds.2009-1405.

PMID:
20435707
[PubMed - indexed for MEDLINE]
Free Article
15.

Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age.

Käyhty H, Ahman H, Eriksson K, Sörberg M, Nilsson L.

Pediatr Infect Dis J. 2005 Feb;24(2):108-14.

PMID:
15702037
[PubMed - indexed for MEDLINE]
16.

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger KS, Hogerman DA, Madore DV, Chang I, Paradiso PR, Malinoski FJ, Kimura A.

Pediatrics. 1998 Apr;101(4 Pt 1):604-11.

PMID:
9521941
[PubMed - indexed for MEDLINE]
17.

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.

Nachman S, Kim S, King J, Abrams EJ, Margolis D, Petru A, Shearer W, Smith E, Moye J, Blanchard S, Hawkins E, Bouquin P, Vink P, Benson M, Estep S, Malinoski F; Pediatric AIDS Clinical Trials Group Study 292 Team.

Pediatrics. 2003 Jul;112(1 Pt 1):66-73.

PMID:
12837869
[PubMed - indexed for MEDLINE]
18.

Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom.

Goldblatt D, Southern J, Ashton L, Andrews N, Woodgate S, Burbidge P, Waight P, Miller E.

Pediatr Infect Dis J. 2010 May;29(5):401-5. doi: 10.1097/INF.0b013e3181c67f04.

PMID:
20010312
[PubMed - indexed for MEDLINE]
19.

Responses to a conjugate pneumococcal vaccine in preterm infants immunized at 2, 3, and 4 months of age.

Moss SJ, Fenton AC, Toomey JA, Grainger AJ, Smith J, Gennery AR.

Clin Vaccine Immunol. 2010 Nov;17(11):1810-6. doi: 10.1128/CVI.00214-10. Epub 2010 Sep 22.

PMID:
20861323
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.

Bermal N, Szenborn L, Chrobot A, Alberto E, Lommel P, Gatchalian S, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S89-96. doi: 10.1097/INF.0b013e318199f901.

PMID:
19325451
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk